Abstract

BackgroundAlthough Diabetes mellitus is a major public health problem in the Middle East and North Africa (MENA) region with high rates of diabetic foot complications, there are only limited data concerning mortality among such a high risk group. Therefore, the main aim of the current study was to assess all-cause mortality and its related predictors among diabetic patients with and without diabetic foot complications.MethodsUsing data from the Saudi National Diabetes Registry (SNDR), a total of 840 patients with type 1 or type 2 diabetes aged ≥25 years with current or past history of diabetic foot ulcer (DFU) or diabetes related lower extremity amputation (LEA) were recruited in 2007 from active patients’ files and followed up to 2013. These patients were compared with an equal number of age and gender matched diabetic patients without foot complication recruited at the same period. All patients were subjected to living status verification at 31st December 2013.ResultsThe all-cause mortality rate among patients with DFU was 42.54 per 1000 person-years and among LEA patients was 86.80 per 1000 person-years among LEA patients for a total of 2280 and 1129 person-years of follow up respectively. The standardized mortality ratio (SMR) (95% CI) was 4.39 (3.55–5.23) and 7.21 (5.70–8.72) for cases with foot ulcer and LEA respectively. The percentage of deceased patients increased by almost twofold (18.5%) among patients with diabetic foot ulcer and more than threefold (32.2%) among patients with LEA compared with patients without diabetic foot complications (10.7%). The worst survival was among patients with LEA at 0.679 and the presence of diabetic nephropathy was the only significant independent risk factor for all-cause mortality among patients with diabetic foot complications. On the other hand, obese patients have demonstrated significantly reduced all-cause mortality rate.ConclusionsDiabetic patients with diabetic foot complications have an excess mortality rate when compared with diabetic counterparts without foot complications and the general population. Early interventions to prevent foot ulceration and consequent LEA as well as all the measurements for reducing the prevalence of microvascular and macrovascular complications should be considered.

Highlights

  • The chronic complications of diabetes in the form of micro-and macrovascular changes are known to be associated with increased risk of all-cause and cardiovascular mortality [1]

  • The percentage of deceased patients increased by almost twofold (18.5%) among patients with diabetic foot ulcer and more than threefold (32.2%) among patients with lower extremity amputation (LEA) compared with patients without diabetic foot complications (10.7%)

  • The worst survival was among patients with LEA at 0.679 and the presence of diabetic nephropathy was the only significant independent risk factor for all-cause mortality among patients

Read more

Summary

Introduction

The chronic complications of diabetes in the form of micro-and macrovascular changes are known to be associated with increased risk of all-cause and cardiovascular mortality [1]. The prevalence of diabetes related morbidities have been considered as one of the highest worldwide with 82% for neuropathy, 31% for retinopathy and 32% for nephropathy [7,8,9]. In this population, the prevalence of diabetic foot complications was 3.30% which included 2.05% foot ulcers, 1.06% amputations and 0.19% gangrenes [10]. The prevalence of diabetic foot disease in Saudi Arabia is similar to what is known internationally [11,12], the large number of diabetic patients would lead to increased number of patients with diabetic foot complications which would put great pressure on both its health system and economy. The main aim of the current study was to assess all-cause mortality and its related predictors among diabetic patients with and without diabetic foot complications

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.